Comparing Glucose-Lowering Drugs for Type 2 Diabetes Treatment According to CVD Risk
In patients who have type 2 diabetes and low cardiovascular risk, receiving metformin as first-line therapy appears justified.
Cardiovascular and Metabolic Disorders
Heart Failure Linked to Highest Mortality Risk in Patients With Recent Type 2 Diabetes
Patients with type 2 diabetes have a greater risk for death after development of heart failure compared with other cardiovascular or renal diagnoses.
Statin Use May Benefit Patients Hospitalized With COVID-19
The use of statins appears to benefit patients hospitalized with COVID-19, according to the findings of a retrospective study conducted in Hubei Province, China.
Early Up-Titration to High-Intensity Statins May Reduce CV Events in Patients at Very High Risk for ASCVD
Up-titration to high-intensity statins early on in the course of treatment was found to be associated with a lower risk for cardiovascular (CV) events compared with no up-titration in patients at very high risk for CV disease.
What Causes Elevated Lipoprotein(a) Levels in Familial Hypercholesterolemia?
Elevated lipoprotein(a) levels was not found to be caused by FH, but may help with clinical recognition of genetic FH.
Stressful Life Events May Increase CHD Risk in Type 2 Diabetes
Higher levels of stressful life events are associated with a higher risk for coronary heart disease among postmenopausal women with type 2 diabetes.
Tildrakizumab Effective for Psoriasis Regardless of Metabolic Syndrome Status
The efficacy of tildrakizumab for the treatment of psoriasis in patients with and without metabolic syndrome was assessed.
Risk for PAD Events May Be Related to Lipoprotein(a) Levels, Reduced by Alirocumab After ACS
The risk for peripheral artery disease events was found to be associated with levels of lipoprotein(a) in patients with recent acute coronary syndrome.
Alirocumab Shows Long-Term Safety and Efficacy in Patients With Statin Intolerance
Alirocumab was found to be well tolerated and to produce long-term reductions in low-density lipoprotein cholesterol in patients who are intolerant to statins.
Recommended Management of Cardiovascular Health in American Indians and Alaska Natives
A scientific statement from the American Heart Association outlines considerations for cardiovascular health in American Indian and Alaska Native populations.
-
Loading...
-
Loading...
Next post in Cardiovascular and Metabolic Disorders
